GA-map® COVID-19 Fecal Test Kit

About Genetic Analysis

Genetic Analysis AS is a diagnostic company focused on unlocking the potential of the human microbiome through its proprietary GA-map® technology platform. A key achievement is the commercialization of the world's first CE-marked IVD test for gut dysbiosis in IBS and IBD, which has been used in over 50 clinical trials. The company is strategically expanding its product portfolio with research-use assays like the MHI GutHealth test, developed with Ferring Pharmaceuticals, and pursuing opportunities in companion diagnostics to support pharmaceutical development.

Therapeutic Areas